Knight Reveals Completion of $100 Million Revolving Credit Facility

Credit Facility Announcement: Knight Therapeutics Inc. has successfully closed the syndication of a US$100 million secured revolving credit facility, expanding from a previous US$50 million facility with National Bank of Canada.

Banking Consortium Expansion: The company has increased its banking consortium to include Citibank N.A., Canadian Imperial Bank of Commerce (CIBC), and The Toronto-Dominion Bank (TD), with NBC serving as the Lead Arranger.

Financial Flexibility and Growth Strategy: The credit facility aims to support Knight's growth strategy, working capital, and corporate purposes, with an accordion feature allowing for an additional US$100 million.

Maturity and Terms: The facility has an initial maturity date of June 17, 2028, with options for annual extensions, and includes customary financial covenants that Knight must maintain throughout the agreement.